Literature DB >> 33463564

Giant cell arteritis: Its ophthalmic manifestations.

Sohan Singh Hayreh1.   

Abstract

Giant cell arteritis (GCA) is the most important medical emergency in ophthalmology, because its most dreaded complication is visual loss, which is preventable if these patients are diagnosed early and treated immediately and aggressively. This is a brief review of GCA, its ophthalmic manifestations, and how to diagnose and manage them.

Entities:  

Keywords:  Anterior ischemic optic neuropathy; Central retinal artery; Giant cell arteritis; posterior ciliary artery occlusion

Year:  2021        PMID： 33463564      PMCID： PMC7933845          DOI： 10.4103/ijo.IJO_1681_20

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN： 0301-4738            Impact factor:   1.848


  54 in total

1.  Giant cell arteritis--a rare cause of fever of unknown origin in India.

Authors:  Rita Sood; H Zulfi; R Ray; R Handa; J P Wali
Journal:  J Assoc Physicians India       Date:  2002-06

2.  Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids?

Authors:  Sohan Singh Hayreh; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

3.  Giant-cell tumors of bone in South India.

Authors:  C R Reddy; P S Rao; K Rajakumari
Journal:  J Bone Joint Surg Am       Date:  1974-04       Impact factor: 5.284

4.  Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness.

Authors:  S Blumberg; D F Giansiracusa; W P Docken; F G Kantrowitz
Journal:  JAMA       Date:  1980-10-10       Impact factor: 56.272

5.  Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Anna Heintzman; Alexander Choe; Philip J Boyer; Charles Grose; John E Carpenter; April Rempel; Nathan Bos; Balasubramaniyam Kandasamy; Kelly Lear-Kaul; Dawn B Holmes; Jeffrey L Bennett; Randall J Cohrs; Ravi Mahalingam; Naresh Mandava; Charles G Eberhart; Brian Bockelman; Robert J Poppiti; Madhura A Tamhankar; Franz Fogt; Malena Amato; Edward Wood; Vikram Durairaj; Steve Rasmussen; Vigdis Petursdottir; Lea Pollak; Sonia Mendlovic; Denis Chatelain; Kathy Keyvani; Wolfgang Brueck; Maria A Nagel
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

6.  Giant cell arteritis in China: a prospective investigation.

Authors:  Zhiping Hu; Qidong Yang; Shan Zeng; Jinghe Li; Xiaoyin Wu; Li Cao; Li Yang; Xinwang Song
Journal:  Angiology       Date:  2002 Jul-Aug       Impact factor: 3.619

7.  Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.

Authors:  F Costello; M B Zimmerman; P A Podhajsky; S S Hayreh
Journal:  Eur J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.597

8.  Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Ophthalmologica       Date:  2003 Jul-Aug       Impact factor: 3.250

Review 9.  Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman; Randy H Kardon
Journal:  Acta Ophthalmol Scand       Date:  2002-08

10.  Comparisons of clinical manifestations and prognosis between giant cell arteritis patients with or without sensorineural hearing loss: A retrospective study of Chinese patients.

Authors:  Xiaotian Chu; Dongmei Wang; Yun Zhang; Yue Yin; Yu Cao; Xinxin Han; Min Shen; Hong Jiang; Xuejun Zeng
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817
View more
  5 in total

1.  Bilateral Anterior Ischemic Optic Neuropathy Accompanied with Unilateral Central Retinal Artery Occlusion in a Biopsy-proven Case of Giant Cell Arteritis.

Authors:  Kaveh Abri Aghdam; Ali Aghajani; Mehdi Khakpour; Mostafa Soltan Sanjari
Journal:  J Ophthalmic Vis Res       Date:  2022-08-15

2.  Rapid-onset bilateral scalp ulceration with visual loss.

Authors:  Sophie Golstein; Thomas Delguste; Frédéric Vandergheynst; Véronique Lesage; Claire Debusscher
Journal:  JAAD Case Rep       Date:  2022-08-10

3.  Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.

Authors:  Javier Loricera; Santos Castañeda; Clara Moriano; Javier Narváez; Vicente Aldasoro; Olga Maiz; Rafael Melero; Ignacio Villa; Paloma Vela; Susana Romero-Yuste; José L Callejas; Eugenio de Miguel; Eva Galíndez-Agirregoikoa; Francisca Sivera; Jesús C Fernández-López; Carles Galisteo; Iván Ferraz-Amaro; Julio Sánchez-Martín; Lara Sánchez-Bilbao; Mónica Calderón-Goercke; Alfonso Casado; José L Hernández; Miguel A González-Gay; Ricardo Blanco
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-22       Impact factor: 3.625

4.  Utility of standard diffusion-weighted magnetic resonance imaging for the identification of ischemic optic neuropathy in giant cell arteritis.

Authors:  L A Danyel; M Miszczuk; C Pietrock; B T Büge; K Villringer; G Bohner; E Siebert
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

5.  Choroidal ischemia as one cardinal sign in giant cell arteritis.

Authors:  Antonio M B Casella; Ahmad M Mansour; Souza Ec; Rodrigo B do Prado; Rodrigo Meirelles; Keye Wong; Salma Yassine; Mário Luiz R Monteiro
Journal:  Int J Retina Vitreous       Date:  2022-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.